| Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread S David, S Reuter, SR Harris, C Glasner, T Feltwell, S Argimon, ... Nature microbiology 4 (11), 1919-1929, 2019 | 565 | 2019 |
| In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator A Cannatelli, MM D'Andrea, T Giani, V Di Pilato, F Arena, S Ambretti, ... Antimicrobial agents and chemotherapy 57 (11), 5521-5526, 2013 | 410 | 2013 |
| MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin A Cannatelli, T Giani, MM D'Andrea, V Di Pilato, F Arena, V Conte, ... Antimicrobial agents and chemotherapy 58 (10), 5696-5703, 2014 | 365 | 2014 |
| Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. M Monaco, T Giani, M Raffone, F Arena, A Garcia-Fernandez, S Pollini Euro surveillance: bulletin Europeen sur les maladies transmissibles …, 2014 | 255 | 2014 |
| Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011 T Giani, F Luzzaro, GM Rossolini | 227 | 2013 |
| mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of … V Di Pilato, F Arena, C Tascini, A Cannatelli, L Henrici De Angelis, ... Antimicrobial agents and chemotherapy 60 (9), 5612-5615, 2016 | 200 | 2016 |
| Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae C Tascini, E Tagliaferri, T Giani, A Leonildi, S Flammini, B Casini, R Lewis, ... Antimicrobial agents and chemotherapy 57 (8), 3990-3993, 2013 | 164 | 2013 |
| In Vivo Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin … A Cannatelli, V Di Pilato, T Giani, F Arena, S Ambretti, P Gaibani, ... Antimicrobial agents and chemotherapy 58 (8), 4399-4403, 2014 | 151 | 2014 |
| Emergence in Italy of Klebsiella pneumoniae Sequence Type 258 Producing KPC-3 Carbapenemase T Giani, MM D'Andrea, P Pecile, L Borgianni, P Nicoletti, F Tonelli, ... Journal of clinical microbiology 47 (11), 3793-3794, 2009 | 147 | 2009 |
| Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant T Giani, F Arena, G Vaggelli, V Conte, A Chiarelli, L Henrici De Angelis, ... Journal of clinical microbiology 53 (10), 3341-3344, 2015 | 134 | 2015 |
| Integrated chromosomal and plasmid sequence analyses reveal diverse modes of carbapenemase gene spread among Klebsiella pneumoniae S David, V Cohen, S Reuter, AE Sheppard, T Giani, J Parkhill, ... Proceedings of the National Academy of Sciences 117 (40), 25043-25054, 2020 | 120 | 2020 |
| Characterization of pABVA01, a Plasmid Encoding the OXA-24 Carbapenemase from Italian Isolates of Acinetobacter baumannii MM D'Andrea, T Giani, S D'Arezzo, A Capone, N Petrosillo, P Visca, ... Antimicrobial agents and chemotherapy 53 (8), 3528-3533, 2009 | 117 | 2009 |
| Escherichia coli from Italy Producing OXA-48 Carbapenemase Encoded by a Novel Tn1999 Transposon Derivative T Giani, V Conte, V Di Pilato, R Aschbacher, C Weber, C Larcher, ... Antimicrobial agents and chemotherapy 56 (4), 2211-2213, 2012 | 99 | 2012 |
| First Detection of the mcr-1 Colistin Resistance Gene in Escherichia coli in Italy A Cannatelli, T Giani, A Antonelli, L Principe, F Luzzaro, GM Rossolini Antimicrobial agents and chemotherapy 60 (5), 3257-3258, 2016 | 98 | 2016 |
| CMY-16, a Novel Acquired AmpC-Type β-Lactamase of the CMY/LAT Lineage in Multifocal Monophyletic Isolates of Proteus mirabilis from Northern Italy MM D'Andrea, E Nucleo, F Luzzaro, T Giani, R Migliavacca, F Vailati, ... Antimicrobial agents and chemotherapy 50 (2), 618-624, 2006 | 87 | 2006 |
| Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe MM D'Andrea, E Literacka, A Zioga, T Giani, A Baraniak, J Fiett, E Sadowy, ... Antimicrobial agents and chemotherapy 55 (6), 2735-2742, 2011 | 86 | 2011 |
| Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy ML Mezzatesta, MM D'Andrea, R Migliavacca, T Giani, F Gona, E Nucleo, ... Clinical microbiology and infection 18 (2), 160-166, 2012 | 78 | 2012 |
| Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: report on the first Italian cases MM D'Andrea, C Venturelli, T Giani, F Arena, V Conte, P Bresciani, ... Journal of clinical microbiology 49 (7), 2755-2758, 2011 | 77 | 2011 |
| Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology … T Giani, F Arena, S Pollini, V Di Pilato, MM D’Andrea, ... Journal of Antimicrobial Chemotherapy 73 (3), 664-671, 2018 | 75 | 2018 |
| Rapid microbiological tests for bloodstream infections due to multidrug resistant Gram-negative bacteria: therapeutic implications DR Giacobbe, T Giani, M Bassetti, A Marchese, C Viscoli, GM Rossolini Clinical Microbiology and Infection 26 (6), 713-722, 2020 | 73 | 2020 |
Marco Maria D'AndreaDep. of Biology, University of Rome "Tor Vergata"在 uniroma2.it 的电子邮件经过验证
